» Articles » PMID: 25012504

Tumor Suppressor WWOX Regulates Glucose Metabolism Via HIF1α Modulation

Overview
Specialty Cell Biology
Date 2014 Jul 12
PMID 25012504
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The WW domain-containing oxidoreductase (WWOX) encodes a tumor suppressor that is frequently lost in many cancer types. Wwox-deficient mice develop normally but succumb to a lethal hypoglycemia early in life. Here, we identify WWOX as a tumor suppressor with emerging role in regulation of aerobic glycolysis. WWOX controls glycolytic genes' expression through hypoxia-inducible transcription factor 1α (HIF1α) regulation. Specifically, WWOX, via its first WW domain, physically interacts with HIF1α and modulates its levels and transactivation function. Consistent with this notion, Wwox-deficient cells exhibited increased HIF1α levels and activity and displayed increased glucose uptake. Remarkably, WWOX deficiency is associated with enhanced glycolysis and diminished mitochondrial respiration, conditions resembling the 'Warburg effect'. Furthermore, Wwox-deficient cells are more tumorigenic and display increased levels of GLUT1 in vivo. Finally, WWOX expression is inversely correlated with GLUT1 levels in breast cancer samples highlighting WWOX as a modulator of cancer metabolism. Our studies uncover an unforeseen role for the tumor-suppressor WWOX in cancer metabolism.

Citing Articles

Genome-wide identification and functional validation of the WW domain containing oxidoreductase gene associated with sleep duration.

Kim S, Kang S, Kim S, Kim H, Kim S, Lee Y Sci Rep. 2025; 15(1):5552.

PMID: 39952983 PMC: 11828923. DOI: 10.1038/s41598-024-81158-8.


WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy.

Liu S, Yang S, Xu M, Zhou Q, Weng J, Hu Z J Immunother Cancer. 2024; 12(11).

PMID: 39500530 PMC: 11552608. DOI: 10.1136/jitc-2024-010422.


Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.

Chen Y, Liu T, Wen K, Hsu C, Sze C, Chang N Int J Mol Sci. 2024; 25(6).

PMID: 38542478 PMC: 10970703. DOI: 10.3390/ijms25063507.


Loss of fragile WWOX gene leads to senescence escape and genome instability.

Cheng H, Huang P, Lai F, Jan M, Chen Y, Chen S Cell Mol Life Sci. 2023; 80(11):338.

PMID: 37897534 PMC: 10613160. DOI: 10.1007/s00018-023-04950-1.


Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.

Rushing B Int J Mol Sci. 2023; 24(17).

PMID: 37686047 PMC: 10487847. DOI: 10.3390/ijms241713242.


References
1.
Grimm C, Willmann G . Hypoxia in the eye: a two-sided coin. High Alt Med Biol. 2012; 13(3):169-75. DOI: 10.1089/ham.2012.1031. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Zhang H, Qian D, Tan Y, Lee K, Gao P, Ren Y . Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A. 2008; 105(50):19579-86. PMC: 2604945. DOI: 10.1073/pnas.0809763105. View

4.
Salah Z, Aqeilan R, Huebner K . WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol. 2010; 6(2):249-59. PMC: 2832309. DOI: 10.2217/fon.09.152. View

5.
Ludes-Meyers J, Kil H, Parker-Thornburg J, Kusewitt D, Bedford M, Aldaz C . Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One. 2009; 4(11):e7775. PMC: 2777388. DOI: 10.1371/journal.pone.0007775. View